This content is machine translated Current psoriasis therapy Comorbidities require careful drug selection Today, biologicals are part of the standard therapy for psoriasis. Pharmaceutical companies are conducting intensive research into new drugs. Experts believe that new biologicals with a similar mechanism of action…
View Post 3 min This content is machine translated Interview with PD Dr. med. Alexander Navarini, Zurich “Patients will have a near-normal quality of life” Recently, PD Alexander Navarini, MD, Zurich, Switzerland, and other researchers discovered a new cell population involved in the pathophysiology of psoriasis. The dermatologist also investigated in clinical trials how well…
